Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15th, to review second-quarter...

Key Takeaway: NEW BRUNSWICK, N.J. , June 17, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15 th , to review second-quarter results. Alex Gorsky , Chairman of the Board of Directors and Chief Executive

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , June 17, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15 th , to review second-quarter results. Alex Gorsky , Chairman of the Board of Directors and Chief Executive Officer; Dominic Caruso , Vice President, Finance and Chief Financial Officer; Paul Stoffels , M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Pharmaceuticals; Joaquin Duato , Worldwide Chairman, Pharmaceuticals; and Louise Mehrotra , Vice President, Investor Relations, will host the call.
Investors and other interested parties may access the conference call in the following ways:
About Johnson & Johnson
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,300 employees at more than 275 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
Last updated: Jun 17, 2014